Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METHYLPHENIDATE for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 8 adverse event reports in the FDA FAERS database where METHYLPHENIDATE was used for Psoriasis.

Most Reported Side Effects for METHYLPHENIDATE

Side Effect Reports % Deaths Hosp.
Drug ineffective 4,924 15.9% 10 265
Off label use 4,842 15.6% 52 274
No adverse event 4,197 13.5% 0 12
Product quality issue 1,728 5.6% 0 11
Disturbance in attention 1,414 4.6% 1 55
Product substitution issue 1,408 4.5% 3 29
Anxiety 1,356 4.4% 3 183
Drug dose omission 1,330 4.3% 0 20
Headache 1,255 4.1% 4 214
Wrong technique in product usage process 1,250 4.0% 3 20
Decreased appetite 1,069 3.5% 5 105
Insomnia 1,033 3.3% 3 197
Aggression 1,003 3.2% 5 154
Toxicity to various agents 913 2.9% 352 578
Fatigue 858 2.8% 12 152

Other Indications for METHYLPHENIDATE

Product used for unknown indication (11,355) Attention deficit/hyperactivity disorder (9,093) Attention deficit hyperactivity disorder (5,500) Narcolepsy (413) Autism spectrum disorder (316) Disturbance in attention (300) Depression (213) Psychomotor hyperactivity (157) Fatigue (124) Anxiety (89)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

METHYLPHENIDATE Full Profile All Psoriasis Drugs METHYLPHENIDATE Demographics METHYLPHENIDATE Timeline